Search results
Lingzhi Hong's 41 research works with 671 citations and 3,209 reads, including: BRIEF REPORT: Real-world efficacy and safety of amivantamab for EGFR-mutant non-small cell lung cancer (NSCLC)
The Biostatistics department at MD Anderson supports the design and analysis of clinical, diagnostic, laboratory, population, and prevention studies. Meet our Biostatistics faculty here.
BACKGROUND. The relationships between lipoprotein-associated phospholipase A2 (Lp-PLA2) level, vasospasm, and clinical outcome of patients with aneurysmal subarachnoid hemorrhage (aSAH) are still unclear. OBJECTIVE.
Executive Team. 2024-2026. Board Chair. President. Vice President. Jing-Zhou Hou, MD, PhD University of Pittsburgh Medical Center Pittsburgh, Pennsylvania. Liang Deng, MD, PhD Memorial Sloan Kettering Cancer Center New York, New York. Cynthia Ma, MD, PhD Washington University School of Medicine St. Louis, Missouri. Committees.
Jun 15, 2024 · This global survey by a collaborative panel of clinical, coding, health management and policy experts, indicates agreement that MAFLD should be coded in ICD-11. The data serves as a foundation for corresponding adjustments in the ICD-11 revision.
Oct 31, 2023 · Liang T, Gao F, Jiang J, Lu YW, Zhang F, Wang Y, Liu N, Fu X, Dong X, Pei J, et al. Loss of phosphatase and tensin homolog promotes cardiomyocyte proliferation and cardiac repair after myocardial infarction.
Clinical Benefit from Docetaxel +/− Ramucirumab Is Not Associated with Mutation Status in Metastatic Non-Small-Cell Lung Cancer Patients Who Progressed on Platinum Doublets and Immunotherapy.
